Portfolio Alerts Watch List Cart

Pharmaceutical

Refine Search

Product Compare (0)
K
KMS Medisurgi Ltd
Score 48/100• Risky
KMS Medisurgi Ltd shows potential in a growing sector, but faces significant risks and inconsistencies in financial performance.
Company’s Health65/100
Valuation 20/100 · PB 5.1601
Technical Avoid
1M — 6M -0.315% 1Y 1.2%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#226
View details ➜
K
Kaya Ltd
Score 48/100• Risky
Kaya Ltd presents significant risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health43/100
Valuation 100/100 · PB -4.8683
Technical Avoid
1M -3.939% 6M 74.507% 1Y 12.044%
Confidence100%
No promoter pledgeHealthy profit margins
#227
View details ➜
H
Hamps Bio Ltd
Score 48/100• Risky
Hamps Bio Ltd presents several risks with inconsistent growth and profitability metrics, alongside high valuation concerns.
Company’s Health81/100
Valuation 60/100 · PB 2.573
Technical Watch
1M 27.349% 6M 21.591% 1Y -51.339%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#228
View details ➜
H
Haleos Labs Ltd
Score 48/100• Risky
Haleos Labs Ltd shows potential in a growing sector, but faces significant risks and inconsistencies in financial performance.
Company’s Health70/100
Valuation 80/100 · PB 1.6849
Technical Avoid
1M 3.985% 6M -12.917% 1Y -13.995%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#229
View details ➜
G
Gian Life Care Ltd
Score 48/100• Risky
Gian Life Care Ltd shows potential in a growing sector, but faces significant challenges in growth consistency and profitability metrics.
Company’s Health37/100
Valuation 100/100 · PB 0.6674
Technical Avoid
1M -21.013% 6M -25.151% 1Y -33.849%
Confidence100%
Low leverage (D/E)Reasonable PB valuation
Weak ROEPromoter pledge present
#230
View details ➜
D
Desh Rakshak Aushdhalaya Ltd
Score 48/100• Risky
Desh Rakshak Aushdhalaya Ltd shows potential in a growing sector, but faces significant challenges in profitability and market sentiment, making it a risky investment.
Company’s Health62/100
Valuation 40/100 · PB 3.7676
Technical Avoid
1M -26.432% 6M 20.848% 1Y 190.44%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#231
View details ➜
C
Cian Healthcare Ltd
Score 48/100• Decent
Cian Healthcare Ltd shows potential for growth but faces challenges in valuation and execution risks.
Company’s Health18/100
Valuation 100/100 · PB 0.3069
Technical Momentum
1M 38.095% 6M 122.956% 1Y 66.824%
Confidence100%
Reasonable PB valuation
Weak ROEPromoter pledge present
#232
View details ➜
B
Bliss GVS Pharma Ltd
Score 48/100• Decent
Bliss GVS Pharma Ltd shows potential but faces challenges in profitability and execution risks. Investors should proceed with caution.
Company’s Health61/100
Valuation 80/100 · PB 1.5184
Technical Avoid
1M 2.38% 6M 33.011% 1Y 26.961%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#233
View details ➜
A
Ambey Laboratories Ltd
Score 48/100• Risky
Ambey Laboratories Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health77/100
Valuation 80/100 · PB 1.3086
Technical Avoid
1M -5.602% 6M 4.297% 1Y -33.527%
Confidence100%
No promoter pledgeReasonable PB valuation
Weak ROEThin margins
#234
View details ➜
A
Amanta Healthcare Ltd
Score 48/100• Risky
Amanta Healthcare Ltd presents a risky investment opportunity due to inconsistent growth and valuation concerns.
Company’s Health58/100
Valuation 40/100 · PB 4.3969
Technical Avoid
1M -7.783% 6M -13.94% 1Y -13.94%
Confidence100%
No promoter pledge
Weak ROEHigh debt/equity
#235
View details ➜
A
Adeshwar Meditex Ltd
Score 48/100• Risky
Adeshwar Meditex Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health64/100
Valuation 100/100 · PB 0.7224
Technical Watch
1M 22.032% 6M 23.333% 1Y -22.917%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#236
View details ➜
A
Amwill Health Care Ltd
Score 48/100• Risky
Amwill Health Care Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
Company’s Health98/100
Valuation 80/100 · PB 1.5607
Technical Avoid
1M -2.439% 6M -42.382% 1Y -42.091%
Confidence100%
Low leverage (D/E)No promoter pledge
#237
View details ➜
A
Alivus Life Sciences Ltd
Score 48/100• Risky
Alivus Life Sciences Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health93/100
Valuation 40/100 · PB 3.9384
Technical Avoid
1M -0.564% 6M -16.916% 1Y -14.449%
Confidence100%
Low leverage (D/E)No promoter pledge
#238
View details ➜
A
Albert David Ltd
Score 48/100• Decent
While Albert David Ltd operates in a promising sector, its inconsistent growth and valuation concerns suggest caution for investors.
Company’s Health66/100
Valuation 80/100 · PB 1.2358
Technical Avoid
1M 8.1% 6M 2.176% 1Y -38.682%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#239
View details ➜
G
Godavari Drugs Ltd
Score 48/100• Risky
Godavari Drugs Ltd presents several risks with inconsistent growth and weak market sentiment, making it a risky investment at this time.
Company’s Health52/100
Valuation 80/100 · PB 1.5146
Technical Avoid
1M 1.995% 6M -2.045% 1Y -29.056%
Confidence100%
Reasonable PB valuation
Weak ROEPromoter pledge present
#240
View details ➜
Showing 226 to 240 of 260 (18 Pages)